Researchers have found that subtle changes in blood metabolites, produced by gut bacteria, may signal the earliest signs of cognitive decline years before symptoms appear.
This insight comes from a study published in Gut Microbes by scientists at the University of East Anglia, who analyzed blood and stool samples from 150 adults aged 50 and older. They identified specific chemical compounds linked to gut microbiota that correlate with early markers of neurodegeneration.
The findings build on growing evidence that the gut-brain axis plays a pivotal role in conditions like Alzheimer’s and Parkinson’s disease. Earlier research had already suggested links between Parkinson’s and sleep disturbances, with potential future use of sleep lab assessments to predict risk years before onset.
Meanwhile, US researchers recently reported in Nature that tau protein levels in blood plasma, combined with age, can help forecast the timeline to Alzheimer’s symptom onset.
Together, these studies point toward a future where routine blood tests could detect neurodegeneration long before clinical diagnosis — offering a window for lifestyle interventions or preventive strategies.
For more on this story, see Gut bacteria signal Parkinson’s years before symptoms appear.
As David Vauzour, lead researcher on the UEA study, stated: “Dementia is one of the greatest challenges for public health of our time.” With over 55 million people affected globally and rising numbers due to aging populations, early detection has never been more urgent.
He added that once symptoms appear, significant brain damage has often already occurred — making early biological warning signs critical for timely action.
In Austria alone, around 25,000 people live with Parkinson’s disease, the fastest-growing neurodegenerative condition worldwide. Although not curable, symptoms are generally manageable — but early diagnosis remains key to better outcomes.
Hope now centers on blood-based biomarkers that could one day transform how we screen for these diseases, shifting from reactive care to proactive prevention.
This follows our earlier report, Gut bacteria chemicals signal early dementia years before symptoms.
How soon could a blood test for early dementia or Parkinson’s risk become available?
While the research shows promise, no timeline for clinical use has been established; further validation and larger trials are needed before such tests could be deployed in healthcare settings.
What specific changes in the blood were linked to early cognitive decline in the study?
The study found that subtle alterations in blood metabolites — chemicals produced by gut bacteria — were associated with early signs of neurodegeneration, detectable long before obvious symptoms.
